363 related articles for article (PubMed ID: 20200274)
1. CD22 x Siglec-G double-deficient mice have massively increased B1 cell numbers and develop systemic autoimmunity.
Jellusova J; Wellmann U; Amann K; Winkler TH; Nitschke L
J Immunol; 2010 Apr; 184(7):3618-27. PubMed ID: 20200274
[TBL] [Abstract][Full Text] [Related]
2. Siglec-G Deficiency Leads to Autoimmunity in Aging C57BL/6 Mice.
Müller J; Lunz B; Schwab I; Acs A; Nimmerjahn F; Daniel C; Nitschke L
J Immunol; 2015 Jul; 195(1):51-60. PubMed ID: 25987743
[TBL] [Abstract][Full Text] [Related]
3. CD22 and Siglec-G: B-cell inhibitory receptors with distinct functions.
Nitschke L
Immunol Rev; 2009 Jul; 230(1):128-43. PubMed ID: 19594633
[TBL] [Abstract][Full Text] [Related]
4. The ligand-binding domain of Siglec-G is crucial for its selective inhibitory function on B1 cells.
Hutzler S; Özgör L; Naito-Matsui Y; Kläsener K; Winkler TH; Reth M; Nitschke L
J Immunol; 2014 Jun; 192(11):5406-14. PubMed ID: 24790146
[TBL] [Abstract][Full Text] [Related]
5. Siglec-G is a B1 cell-inhibitory receptor that controls expansion and calcium signaling of the B1 cell population.
Hoffmann A; Kerr S; Jellusova J; Zhang J; Weisel F; Wellmann U; Winkler TH; Kneitz B; Crocker PR; Nitschke L
Nat Immunol; 2007 Jul; 8(7):695-704. PubMed ID: 17572677
[TBL] [Abstract][Full Text] [Related]
6. Copresentation of antigen and ligands of Siglec-G induces B cell tolerance independent of CD22.
Pfrengle F; Macauley MS; Kawasaki N; Paulson JC
J Immunol; 2013 Aug; 191(4):1724-31. PubMed ID: 23836061
[TBL] [Abstract][Full Text] [Related]
7. Siglec-G deficiency leads to more severe collagen-induced arthritis and earlier onset of lupus-like symptoms in MRL/lpr mice.
Bökers S; Urbat A; Daniel C; Amann K; Smith KG; Espéli M; Nitschke L
J Immunol; 2014 Apr; 192(7):2994-3002. PubMed ID: 24600033
[TBL] [Abstract][Full Text] [Related]
8. Sialic Acid Ligand Binding of CD22 and Siglec-G Determines Distinct B Cell Functions but Is Dispensable for B Cell Tolerance Induction.
Özgör L; Meyer SJ; Korn M; Terörde K; Nitschke L
J Immunol; 2018 Oct; 201(7):2107-2116. PubMed ID: 30143587
[TBL] [Abstract][Full Text] [Related]
9. Siglec-G regulates B1 cell survival and selection.
Jellusova J; Düber S; Gückel E; Binder CJ; Weiss S; Voll R; Nitschke L
J Immunol; 2010 Sep; 185(6):3277-84. PubMed ID: 20729333
[TBL] [Abstract][Full Text] [Related]
10. CD22 regulates early B cell development in BOB.1/OBF.1-deficient mice.
Samardzic T; Gerlach J; Muller K; Marinkovic D; Hess J; Nitschke L; Wirth T
Eur J Immunol; 2002 Sep; 32(9):2481-9. PubMed ID: 12207332
[TBL] [Abstract][Full Text] [Related]
11. B cell defects in SLP65/BLNK-deficient mice can be partially corrected by the absence of CD22, an inhibitory coreceptor for BCR signaling.
Gerlach J; Ghosh S; Jumaa H; Reth M; Wienands J; Chan AC; Nitschke L
Eur J Immunol; 2003 Dec; 33(12):3418-26. PubMed ID: 14635051
[TBL] [Abstract][Full Text] [Related]
12. B cell antigen receptor-evoked calcium influx is enhanced in CD22-deficient B cell lines.
Nadler MJ; McLean PA; Neel BG; Wortis HH
J Immunol; 1997 Nov; 159(9):4233-43. PubMed ID: 9379018
[TBL] [Abstract][Full Text] [Related]
13. CD22 and Siglec-G regulate inhibition of B-cell signaling by sialic acid ligand binding and control B-cell tolerance.
Nitschke L
Glycobiology; 2014 Sep; 24(9):807-17. PubMed ID: 25002414
[TBL] [Abstract][Full Text] [Related]
14. Siglec-G is a B-1 cell inhibitory receptor and also controls B cell tolerance.
Nitschke L
Ann N Y Acad Sci; 2015 Dec; 1362():117-21. PubMed ID: 26194636
[TBL] [Abstract][Full Text] [Related]
15. CD22 serves as a receptor for soluble IgM.
Adachi T; Harumiya S; Takematsu H; Kozutsumi Y; Wabl M; Fujimoto M; Tedder TF
Eur J Immunol; 2012 Jan; 42(1):241-7. PubMed ID: 21956693
[TBL] [Abstract][Full Text] [Related]
16. Genetic interdependence of Lyn and negative regulators of B cell receptor signaling in autoimmune disease development.
Tsantikos E; Maxwell MJ; Kountouri N; Harder KW; Tarlinton DM; Hibbs ML
J Immunol; 2012 Aug; 189(4):1726-36. PubMed ID: 22798664
[TBL] [Abstract][Full Text] [Related]
17. CD22: a multifunctional receptor that regulates B lymphocyte survival and signal transduction.
Tedder TF; Poe JC; Haas KM
Adv Immunol; 2005; 88():1-50. PubMed ID: 16227086
[TBL] [Abstract][Full Text] [Related]
18. Peripheral B cell receptor editing may promote the production of high-affinity autoantibodies in CD22-deficient mice.
Yarkoni Y; Fischel R; Kat I; Yachimovich-Cohen N; Eilat D
Eur J Immunol; 2006 Oct; 36(10):2755-67. PubMed ID: 16983722
[TBL] [Abstract][Full Text] [Related]
19. Analysis of Lyn/CD22 double-deficient B cells in vivo demonstrates Lyn- and CD22-independent pathways affecting BCR regulation and B cell survival.
Ferry H; Crockford TL; Silver K; Rust N; Goodnow CC; Cornall RJ
Eur J Immunol; 2005 Dec; 35(12):3655-63. PubMed ID: 16278813
[TBL] [Abstract][Full Text] [Related]
20. Expansion of CD22lo B cells in the spleen of autoimmune-prone flaky skin mice.
Mattsson N; Duzevik EG; Pelsue SC
Cell Immunol; 2005 Apr; 234(2):124-32. PubMed ID: 16054613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
